Page 7 - Keeping It News Today : Breaking News, Live Updates & Top Stories | Vimarsana

with diabetes. but the impact his life had on music. >> reading the obituaries what strikes me is that this guy was important not just in the music business, but in the culture. he desegmeregated that show. he was the first show to have black teenagers appear on it. he said the only time he got swe sweaty palms in an interview was when he interviewed a black american youth. >> he talks about that integration, you don't get the sense that this was a big planned out, plotted out strategy. >> no. >> it was just one of those thing that is -- >> no. >> joe levy is with us this morning. it...

endorsements but a bit of a dark cloud on the horizon. more on that in just a moment, but, first, his fight for the gop nomination. a new nbc news/"wall street journal" poll shows him with a commanding lead over mitt romney. the other candidates trailing far behind. paul steinhauser is in washington. paul, the same poll shows gingrich struggling in a head-to-head race against president obama. tell us about that. >> that horse race poll and two others indicate the same thing. way ahead in the horse race. look at this, hypothetical matchups next november. president obama versus gingric...

>r p a fierce gu or out nep out near a h international reporters are staying. reberebels say they're making r gains, a a reuters ease report says forces were seen advancing. gadhafi's government says the rebellion is failing. a government. embattled bashar al assad is giving an interview to state-run television this hour to talk about his country's future. among other things, he is expected to discuss reforms and political and economic pressure from the west. al assad faces growing calls to end his brutal five-month crackdown on opposition protesters. the families of two ameri...

Latest updates on this topic from reliable sources.

Ask you, why have doctors been prescribing this? >> well, you know, i think there was enthusiasm in 2008 and there are doctors that will continue to prescribe this because the way medicine works in a population of women, the drug still may have some benefit and cannot say that across the board. the goal as you might say to figure out who will benefit and who's not and we don't know the answer to that so the fda has to look at the aggregate. overall, on the up and up looking at everybody, we think that the benefits do not outweigh the risks, we do not think it increases survival. in europe, as ...